Interview with Nick Culbertson, CEO & Co-Founder of ProtenusInterview with Nick Culbertson, CEO & Co-Founder of Protenus
Drug Diversion Insights with Terri Vidals
Nick Culbertson discusses how Protenus uses AI to tackle drug diversion in healthcare.
20:05•29 Jun 2021
Nick Culbertson on Revolutionizing Drug Diversion Surveillance with Protenus
“We're able to deliver virtually accuracy with our analytics, using machine learning and artificial intelligence, and really set a higher standard for how compliance can be enforced at scale and help create that culture of compliance generally.”
Imagine a world where advanced technology can help healthcare professionals detect and prevent drug diversion before it spirals out of control. In this episode, pharmacist Terri Vidals sits down with Nick Culbertson, the CEO and co-founder of Protenus, to discuss how their innovative software is making this a reality. Protenus utilizes machine learning and artificial intelligence to spot both obvious and hidden signs of drug diversion, offering a robust end-to-end analytical solution that goes beyond traditional methods.
This conversation dives into the complexities of drug diversion, from the reverse distribution space to the broader impact on healthcare systems. Nick also shares insights from Protenus' annual Drug Diversion Digest, shedding light on the latest trends and challenges in the field. Whether you're a healthcare worker, a policy maker, or someone interested in the intersection of technology and healthcare, this episode offers valuable perspectives on creating a culture of compliance and safety.
Tune in to learn how Protenus is paving the way for a safer healthcare environment.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.